Skip to main content
Decorative image of the COVID-19 Learning Lounge

Establishing a Distribution Network For COVID-19 Monoclonal Antibody Therapy


The University of Pittsburgh Medical Center (UPMC) released a study showing that monoclonal antibody therapy can help certain people fight COVID-19 and keep them from progressing to serious illness and death. This study demonstrates how they were able to distribute and administer agents across 35 hospitals, several senior community facilities and skilled nursing facilities (SNF), and numerous outpatient providers. Because administering these infusions comes with logistical challenges, UPMC addresses concerns and shares recommendations in this study including infection prevention measures.


The study reveals how a large health system overcame logistical challenges to deliver monoclonal antibody therapy.

Read Time: 6 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

U.S. bioMérieux Solutions

Us Solutions

COVID-19 Testing Solutions for Healthcare

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.


Oxford Academic
July 7, 2021